| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 9,805 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 30,845 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 45,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 56,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 50,974 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 95,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 110,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 82,500 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChiefDERIV | May 14 | D | 108,622 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 25,840 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 11,284 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 3,372 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 4,909 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 25,840 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | A | 25,840 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 12,920 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | A | 12,920 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 10,030 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | A | 10,030 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | D | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | A | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | May 14 | U | 1,177,222 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | Jan 28 | A | 25,840 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | Jan 22 | S | 5,928 | $21.77 | $129K |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | Jan 20 | S | 909 | $19.79 | $18K |
| Apellis Pharmaceuticals, Inc. | APLS | Pascal DeschateletsChief | Jan 13 | S | 2,277 | $22.19 | $51K |